Potter’s House Apothecary, Inc., Peoria, AZ
Is Potter’s House Apothecary, Inc. registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Potter’s House Apothecary, Inc. hold a Arizona pharmacy license?
State board of pharmacy records for Arizona are not checked: the board’s website, which hosts its license verification and board orders, answers automated requests with a bot challenge, and this index does not work around blocks. The Texas State Board of Pharmacy also lists nonresident license 36253 for POTTER'S HOUSE APOTHECARY, PEORIA, AZ, status Active, as of Nov 15, 2026. The Colorado State Board of Pharmacy also lists nonresident license OSP 7935 for Potter's House Apothecary LLC, Peoria, AZ, status Active and license OSP 6166 for Potter's House Apothecary, Peoria, AZ, status Expired, as of Nov 15, 2026. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054017874 for POTTERS HOUSE APOTHECARY, PEORIA, AZ, status NOT RENEWED, as of Nov 13, 2026.
Has Potter’s House Apothecary, Inc. had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 untitled letter (Sep 15, 2021), 1 state referral letter (May 16, 2022) and 1 FMD-145 letter (May 16, 2022) for Potter’s House Apothecary, Inc. State board of pharmacy records for Arizona are not checked: the board’s website, which hosts its license verification and board orders, answers automated requests with a bot challenge, and this index does not work around blocks. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Potter’s House Apothecary, Inc.
- Location
- Peoria, AZ
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 1
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- May 16, 2022
- FDA Data Dashboard inspections
- No matching site found
- Form 483 text on this page
- 1 Form 483, 2 observations
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Potter’s House Apothecary, Inc., a 503A facility, with 4 dated actions.
| Document | |||
|---|---|---|---|
| May 16, 2022 | State referral letter | Referral Letter to the Arizona State Board of Pharmacy Issued 05/16/2022 | FDA copy (archived) |
| May 16, 2022 | FMD-145 letter | FMD-145 Letter Issued 05/16/2022 | Not linked by FDA |
| Sep 15, 2021 | Untitled letter | Untitled Letter Issued 09/15/2021 | FDA copy (archived) |
| Sep 16, 2020 | Form 483 | 483 Issued 9/16/2020 | FDA copy (archived) |
A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA’s published Form 483 for this site has 2 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.
Inspection Sep 2, 2020: 2 observations
- Firm on the cover
- Potter's House Apothecary, Inc., 21585 N. 77th Ave., #1500, Peoria, AZ 85382
- FEI number
- 3011701621
- Establishment type on the cover
- producer of sterile and non-sterile drugs THIS DOCUMENT LISTS OBSERVATIONS MADE BY THE FDA REPRESENTATIVE(S) DURING THE INSPECTION OF YOUR FACILITY. THEY ARE INSPECTIONAL OBSERVATIONS: AND DO NOT REPRESENT A FINAL AGENCY DETERMINATION REGARDING YOUR COMPLIANCE. IF YOU HAVE AN OBJECTION REGARDING AN OBSERVATION, OR HAVE IMPLEMENTED, OR PLAN TO IMPLEMENT CORRECTIVE ACTION IN RESPONSE TO AN OBSERVATION, YOU MAY DISCUSS THE OBJECTION OR ACTION WITH THE FDA REPRESENTATIVE(S) DURING THE INSPECTION OR SUBMIT THIS INFORMATION TO FDA AT THE ADDRESS ABOVE. IF YOU HAVE ANY QUESTIONS, PLEASE CONTACT FDA AT THE PHONE NUMBER AND ADDRESS ABOVE.
- FDA district office on the cover
- Denver District Office 6th Ave. and Kipling St., Bldg. 20 Denver, CO 80225
- Matched to this page by
- firm name, city and state on the cover; linked from actions page
- FDA document
- Read the full 483 (Internet Archive copy FDA links)
Observation 1
Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the room to produce aseptic conditions.
Specifically,
A) On 09/03/2020, 1 observed an approximately 8x5 inch splatter of reddish-purple substance on the perforated rnetal <Redacted B4> and HEPA filter inside the ISO 5 <Redacted B4> LAFW, model <Redacted B4>, used to produce approximately <Redacted B4> of sterile drugs. The residue/staining was present after the technician performed a "deep clean" prior to production, and the firm was unable to determine w.hen the splatter occurred. The firm continued production of sterile drugs inside the ISO 5 LAFW throughout the inspection. I observed production of lot <Redacted B4>;.
B) Technicians remove sterile wipes from the manufacturers packaging and store them on a cart in the ISO 7 buffer room indefinitely. There was no documentation available which detailed how long the wipes were on the cart exposed to the environment within the ISO 7 buffer room. ...
Observation 2
Personnel were observed to manually contact a product contact surface while conducting aseptic operations.
OBSERVATlON 3
ISO-5 classified areas were not certified under dynamic conditions.
Specifically, unidirectional airflow in the ISO 5 LAFW and ISO 5 BSC used to produce all teri le drugs was not verified under operational conditions:
A) The studies did not use sufficient smoke or duration to visualize unidirectional airflow.
B) The studies did not include a <Redacted B4> which sterile technicians use to dissolve bulk drug substances in most sterile finished drugs. I observed the technician use a <Redacted B4> during sterile production in the ISO 5 LAFW on 09/03/2020 and 09/09/2020.
C) The studies did not include items such as vials, sterilizing <Redacted B4> syringes, and large diluent containers on the primary workspace. I observed the technician place all items needed for production onto the primary workspace during sterile production in the ISO 5 LAFW on 09/03/2020 and 09/09/2020.
D) The studies did not show the interaction between the smoke and the technician. ...
State board of pharmacy records
State board of pharmacy records for Arizona are not checked: the board’s website, which hosts its license verification and board orders, answers automated requests with a bot challenge, and this index does not work around blocks.
Nonresident licenses in other states
These boards list a nonresident license whose record names this pharmacy’s own name, city and state.
Texas State Board of Pharmacy, file dated Nov 15, 2026 (Texas).
| License | Type as the board gives it | Name on the board record | Location | Status | Prior disciplinary orders (file flag) |
|---|---|---|---|---|---|
| 36253 | Non Resident Sterile Compounding | POTTER'S HOUSE APOTHECARY | PEORIA, AZ | Active | No |
Colorado State Board of Pharmacy, file dated Nov 15, 2026 (Colorado).
Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| 054017874 | LICENSED PHARMACY | POTTERS HOUSE APOTHECARY | PEORIA, AZ | NOT RENEWED |
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: FDA Form 483 Frequently Asked Questions
- Texas State Board of Pharmacy license file
- Colorado State Board of Pharmacy license file
- Illinois Department of Financial and Professional Regulation license file
- Texas State Board of Pharmacy disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.